Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Medtronic CFO: This Is the Best Pipeline We've Ever Had
Medical Devices and Diagnostics Industry
Fri, 03/15/24 - 11:27 am
Medtronic
Medtech
diabetes
pulsed field ablation
How the Ozempic gold rush is causing ‘deeply concerning’ shortage for diabetes patients
Biopharma Reporter
Wed, 03/13/24 - 11:16 am
Ozempic
Novo Nordisk
GLP-1
diabetes
drug shortages
Roche to take on Abbott, Dexcom with its first CGM
Medtech Dive
Fri, 03/8/24 - 11:13 am
Medtech
Roche
CGMs
diabetes
Abbott Labs
DexCom
Accu-Chek Smartguide
FDA clears 1st OTC continuous glucose monitor
Beckers Hospital Review
Wed, 03/6/24 - 11:22 am
Medtech
DexCom
Stelo Glucose Biosensor
CGMs
blood glucose monitoring
FDA
diabetes
Novo kidney trial finds Ozempic cuts cardiac risks in diabetics
Reuters
Tue, 03/5/24 - 11:52 am
Novo Nordisk
Ozempic
clinical trials
diabetes
chronic kidney disease
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
Motley Fool
Sun, 03/3/24 - 09:48 pm
Ozempic
Abbott Labs
Medtech
diabetes
CGMs
Eli Lilly Has More Than an Ozempic Competitor -- Much More
Motley Fool
Wed, 02/21/24 - 11:14 am
Eli Lilly
obesity
cancer
diabetes
psoriasis
Alzheimer's disease
Eli Lilly settles Minnesota lawsuit over insulin pricing
Reuters
Wed, 02/7/24 - 11:19 am
Eli Lilly
legal
insulin
drug pricing
diabetes
Minnesota
Fractyl Breaks the Medical Device IPO Drought with New Offering
Medical Devices and Diagnostics Industry
Sun, 02/4/24 - 12:37 pm
Fractyl Health
IPOs
diabetes
obesity
Medtech
Will Novo Nordisk Be a $1 Trillion Company by 2030?
Motley Fool
Tue, 01/30/24 - 10:40 am
Novo Nordisk
obesity
diabetes
kidney disease
Lilly's weight-loss drug Mounjaro coming to UK after pen cleared
Reuters
Thu, 01/25/24 - 09:00 pm
Eli Lilly
Mounjaro
UK
obesity
diabetes
7 JPM Announcements You Don’t Want to Miss
MedCity News
Fri, 01/12/24 - 09:51 am
JPMHC 2024
Boston Scientfic
M&A
Axonics
Amazon
JNJ
Mayo Clinic
artificial intelligence
diabetes
Abbott Labs
Innovaccer
Merck
JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage
Medical Marketing and Media
Thu, 01/11/24 - 11:18 am
JPMHC 2024
obesity
diabetes
diabesity
Novo Nordisk
Eli Lilly
Abbott CEO Touts Libre as ‘Most Successful Medtech Product in History’
Medical Devices and Diagnostics Industry
Wed, 01/10/24 - 06:21 pm
Abbott Labs
FreeStyle Libre
CGMs
diabetes
Medtech
FDA warns about counterfeit versions of Novo's diabetes drug Ozempic
Reuters
Fri, 12/22/23 - 09:40 am
Novo Nordisk
FDA
Ozempic
diabetes
drug counterfeiting
Structure shares sink as obesity pill misses expectations in small study
BioPharma Dive
Mon, 12/18/23 - 10:17 pm
Structure Therapeutics
obesity
clinical trial
GSBR-1290
diabetes
With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics
Fierce Pharma
Tue, 11/21/23 - 10:54 pm
Sanofi
Mylan
legal
FTC
insulin
diabetes
Beyond insulin: Medical expands patient access to diabetes supplies
Medical Marketing and Media
Sun, 11/19/23 - 09:34 pm
insulin
diabetes
Medi-Cal
Novo Nordisk sets aside $6bn to boost production capacity
Pharmaphorum
Fri, 11/10/23 - 10:11 am
Novo Nordisk
diabetes
obesity
drug manufacturing
Novo Nordisk to discontinue Levemir insulin in U.S. market
Reuters
Wed, 11/8/23 - 09:59 pm
Novo Nordisk
Levemir
insulin
diabetes
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »